Dr Thomas Jason Sendrijas Simon, MD in Lafayette, LA - Student in an Organized Health Care Education/Training Program

Dr Thomas Jason Sendrijas Simon, MD is a Student In An Organized Health Care Education/training Program physician based in Lafayette, Louisiana. Dr Thomas Jason Sendrijas Simon is licensed to practice in Louisiana (license number 332105) and his current practice location is 2390 W Congress St, Lafayette, Louisiana. He can be reached at his office (for appointments etc.) via phone at (337) 261-6156.

NPI number for Dr Thomas Jason Sendrijas Simon is 1245807957 and his current mailing address is 2390 W Congress St, Lafayette, Louisiana. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1245807957.

Contact Information

	Dr Thomas Jason Sendrijas Simon, MD
	2390 W Congress St, Lafayette, LA 70506-4205
	(337) 261-6156
	Not Available

Physician's Profile

Full Name	Dr Thomas Jason Sendrijas Simon
Gender	Male
Speciality	Student In An Organized Health Care Education/training Program
Location	2390 W Congress St, Lafayette, Louisiana
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1245807957
Provider Enumeration Date: 06/10/2021
Last Update Date: 07/01/2022

Medical Identifiers

Medical identifiers for Dr Thomas Jason Sendrijas Simon such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1245807957	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
2084N0400X	Psychiatry & Neurology - Neurology	12985 (Georgia)	Secondary
390200000X	Student In An Organized Health Care Education/training Program	(* (Not Available))	Secondary
390200000X	Student In An Organized Health Care Education/training Program	332105 (Louisiana)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Thomas Jason Sendrijas Simon is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Thomas Jason Sendrijas Simon, MD 2390 W Congress St, Lafayette, LA 70506-4205 Ph: (318) 805-3633	Dr Thomas Jason Sendrijas Simon, MD 2390 W Congress St, Lafayette, LA 70506-4205 Ph: (337) 261-6156

News Archive

MedAssets to demonstrate how its solutions help optimize hospital's revenue cycle

MedAssets, Inc. will demonstrate how its revenue cycle management and spend management solutions help hospitals and healthcare systems reduce costs, increase efficiency and increase revenue at the inaugural HFMA Virtual Trade Show, to be held on January 12-13, 2010.

CDC director gives health system failing grade on prevention

Memphis Commercial Appeal: "The American health care system gets an 'F' when it comes to acting on a handful of prevention methods that have the potential to save the most lives. That failing grade came from Dr. Thomas Frieden, director of the Centers for Disease Control and Prevention, in a Wednesday speech to members of the National Association of County and City Health Officials gathered here for their annual conference at Cook Convention Center."

Akela reports total consolidated revenues of $4.2 million for three months ended March 31, 2011

Akela Pharma, Inc., a drug development company with its lead product, Fentanyl TAIFUN, being developed for the treatment of breakthrough cancer pain and the company's wholly owned subsidiary, PharmaForm, a leading specialty contract service provider in the area of pharmaceutical dosage form development and manufacturing, today announced its financial results for the three months and year ended March 31, 2011.

Prevalence of mental health diagnoses increases with long duration of opioid use

Most patients taking opioids for low back pain or other pain syndromes are prescribed low-to moderate doses, but a substantial number are given higher doses. Although there is no consensus on an absolute limit because tolerance varies over time among individual patients, what is known, however, is higher does are associated with elevated risks for side effects, addiction, overdoses and death.

Dr Thomas Jason Sendrijas Simon, MD - Student in an Organized Health Care Education/Training Program in Lafayette, LA